Cancerappy: Using AI to Advance Cancer Research
Since 2019, Cancerappy has been harnessing the power of artificial intelligence to transform cancer research, from improving detection and diagnosis to developing more effective treatments with fewer side effects. We’re putting AI to work in areas like genomics, protein structure prediction, and drug discovery.
Here’s how AI drives our programs:
-
New Drug Development: AI speeds up drug discovery, making it faster, more cost-effective, and precise. It helps us screen drugs, predict multi-target effects, and find new uses for existing drugs.
-
Identifying Targets: AI enables us to design proteins and identify new therapeutic targets, opening doors to innovative treatments.
-
Handling Big Data: Cancer research generates huge data sets. AI helps us spot patterns, clean up data, and draw accurate conclusions.
-
Linking Data for Deeper Insights: By connecting data from diverse technologies, AI gives us a richer perspective and opens new research pathways.
At Cancerappy, AI is more than a tool—it’s a game-changer in our mission to make cancer treatments more effective and targeted.
Cancerappy at #Bventure24
We’re back at Bventure! Cancerappy is actively participating in this innovation event through the University of Deusto, joining the roundtable discussion, “The Value of Talent in an AI Startup.” On Tuesday, Oct 15th, our CEO will share insights on how AI is impacting our work and driving progress in our field. Don’t miss it!
CancerAppy to Speak at ACCESS CHINA Partnering Forum
We are glad to announce that Luis Martin, the Chief Executive Officer of CancerAppy, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
China health innovation ecosystem
A Cancerappy delegation has participated in a roadshow of European companies to learn about the innovative health ecosystem in the Shanghai and Wuxi area.
Our CEO has had the opportunity to hold various meetings with different agents of the innovation ecosystem, especially in the health sector, including investors, local government officials, leaders of research and innovation centers, as well as biotech companies and laboratories.
We have been able to observe first-hand how China has evolved to reach a peak of technological innovation in the health sector that is enviable and leading in the world.
From all these meetings, we have achieved several collaboration agreements that represent the beginning of a great business adventure that Cancerappy is going to begin imminently.